Last update:

Weight management news

Is poor sleep contributing to the country's weight issues?

Some 70% of teens trying to adapt to a fall schedule are missing out on sleep. Early bells and tough classes combine with delayed biological clocks during adolescence, keeping their nightly sleep duration during the school ...

GLP-1 use among young children with obesity in US remains rare but is rising rapidly

Although the number of U.S. children under age 12 with obesity who are prescribed the weight-loss drugs Saxenda, Wegovy and Zepbound remains low, it was 310 times higher in June 2026 than in 2019, when the drugs were first ...

Some hair loss in men is linked to weight loss drug use

Men already genetically at risk for the most common form of hair loss have a 7% added risk of losing their hair if they use drugs like Ozempic, Wegovy and Zepbound for type 2 diabetes and obesity, a new study shows.

Why men can struggle with weight-loss initiatives

A new study has identified why many men struggle with weight loss, finding that traditional diet programs are often perceived as too restrictive and primarily aimed at women. The research, published in PLOS One and led by ...

GLP-1 meds prompt rethink of obesity and eating disorder care

Obesity and eating disorders have traditionally been treated as separate areas of health care—but the rapid rise of GLP-1 medicines is increasingly bringing the two together. Adelaide University researchers say the growing ...

Diet tips during cancer treatment

Cancer treatments can take a toll on a person's body. A patient's treatment may cause nausea, changes in appetite, taste and smell, diarrhea, or constipation, making it harder to meet their nutritional needs. Fortunately, ...

Fructose emerges as a key driver of metabolic disease

A new report, published in Nature Metabolism, is shedding light on the distinct and underappreciated role of fructose in driving disease, separate from its role as a simple source of calories.

Weight loss leads to notable muscle loss, study finds

A new UNC School of Medicine study of incretin-based medications, including newer medications such as semaglutide and tirzepatide that are widely prescribed for type 2 diabetes and obesity, finds they are associated with ...

Study challenges decades-old puzzle about childhood body fat

A new study published in The Journal of Nutrition, offers new insights into a decades-old puzzle in childhood obesity. The study found that while body mass index (BMI) starts to rise in early childhood during a stage known ...

Study finds that whole-fat milk lowers risk of child obesity

New research from the University of Toronto suggests that children who drink whole-fat milk in early childhood may have lower odds of obesity in middle childhood than those who drink reduced-fat milk. The study adds to emerging ...